Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-071539
Filing Date
2011-03-21
Accepted
2011-03-18 21:19:04
Documents
12
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d20f.htm 20-F 1758386
2 LIST OF SUBSIDIARIES dex81.htm EX-8.1 8359
3 CERTIFICATIONS UNDER SECTION 302; PEER M. SCHATZ dex121.htm EX-12.1 5853
4 CERTIFICATIONS UNDER SECTION 302; ROLAND SACKERS dex122.htm EX-12.2 5758
5 CERTIFICATIONS UNDER SECTION 906; PEER M. SCHATZ & ROLAND SACKERS dex131.htm EX-13.1 4559
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex151.htm EX-15.1 3166
  Complete submission text file 0001193125-11-071539.txt   14368508

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT qgen-20101231.xml EX-101.INS 1944394
8 XBRL TAXONOMY EXTENSION SCHEMA qgen-20101231.xsd EX-101.SCH 95515
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qgen-20101231_cal.xml EX-101.CAL 139366
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qgen-20101231_def.xml EX-101.DEF 276017
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE qgen-20101231_lab.xml EX-101.LAB 750935
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qgen-20101231_pre.xml EX-101.PRE 572294
Mailing Address SPOORSTRAAT 50 KJ VENLO P7 5911
Business Address SPOORSTRAAT 50 KJ VENLO P7 5911 31-77-320-8400
QIAGEN NV (Filer) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-28564 | Film No.: 11699573
SIC: 2836 Biological Products, (No Diagnostic Substances)